The impact of self- and physician-administered cancer treatment on work productivity and healthcare utilization.

Autor: Seabury SA; University of Southern California, USC Schaeffer Center, 635 Downey Way, VPD Suite 414C, Los Angeles, CA, 90089-3333, United States. Electronic address: seabury@usc.edu., Frasco MA; Precision Health Economics, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, CA, 90025, United States., van Eijndhoven E; Precision Health Economics, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, CA, 90025, United States., Sison S; Precision Health Economics, 11100 Santa Monica Boulevard, Suite 500, Los Angeles, CA, 90025, United States., Zacker C; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, United States.
Jazyk: angličtina
Zdroj: Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2018 May; Vol. 14 (5), pp. 434-440. Date of Electronic Publication: 2017 May 22.
DOI: 10.1016/j.sapharm.2017.05.009
Abstrakt: Background: Lost productivity in the workplace represents a significant portion of the economic burden of cancer in the United States. Cancer treatments have historically been physician-administered, while recent innovations have led to the development of self-administered, usually oral, agents. Self-administered treatments have the potential to reduce healthcare utilization and time away from work, but the magnitude of these effects is unknown.
Objective: To compare the effects of self- and physician-administered cancer treatment on work productivity and health care utilization.
Methods: Cancer subtypes with self- and physician-administered treatment options were selected. Patients with female breast, or lung or bronchus cancer diagnosed in 2004-2013 were identified in the Truven Health Analytics Commercial Claims and Encounters and Health and Productivity Management databases. Using multivariate regression models, work productivity and healthcare utilization were compared for patients receiving self- versus physician-administered treatment in the 12 months after initial diagnosis. Work productivity outcomes included the number of sick days and short-term disability claims.
Results: One month of self- versus physician-administered treatment significantly reduced cancer-related outpatient services, doctor visits, and infusions in the 12 months after initial diagnosis for both cancers of interest. In addition, breast and lung or bronchus cancer patients who received self-administered treatment were less likely to have short-term disability claims, and breast cancer patients with non-metastatic disease who received self-administered treatment had significantly fewer sick days.
Conclusions: Self-administered cancer treatment was associated with fewer cancer-related outpatient services and reduced time away from work compared to physician-administered cancer treatment.
(Copyright © 2017 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: